Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neuroendocrine dysfunction in psychotic disorders (excluding ACTH).

Bailliere'S Clinical Endocrinology and Metabolism

|March 1, 1991

Summary

This review examines neuropeptide and neuroendocrine changes in schizophrenia and affective disorders. Findings suggest dopamine dysfunction in schizophrenia and disrupted neuroendocrine control in affective disorders, potentially indicating vulnerability markers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression.

Psychological medicine·2016

Same author

Altered hippocampal function in major depression despite intact structure and resting perfusion.

Psychological medicine·2016

Same author

The interrelationship between attentional and executive deficits in major depressive disorder.

Acta psychiatrica Scandinavica·2016

Same author

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2016

Same author

Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions.

Psychological medicine·2015

Same author

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Journal of psychopharmacology (Oxford, England)·2015

Area of Science:

Neuroscience
Psychiatry
Endocrinology

Background:

Functional psychoses, including schizophrenia and affective disorders, involve complex neurobiological alterations.
Neuropeptides and neuroendocrine systems play crucial roles in mood regulation and cognitive function.
Previous research indicates potential links between these systems and the pathophysiology of psychotic illnesses.

Purpose of the Study:

To review and synthesize current findings on neuropeptide and neuroendocrine alterations in schizophrenia and affective disorders.
To explore the potential roles of these changes as markers or mechanisms of vulnerability in these conditions.
To identify future research directions in understanding the neurobiology of psychotic illnesses.

Main Methods:

Systematic review of existing literature on neuropeptide and neuroendocrine studies.
Analysis of findings related to schizophrenia and major affective disorders.
Synthesis of evidence linking neurobiological changes to clinical presentations.

Main Results:

Schizophrenia is associated with central dopamine dysfunction and hypothalamic/limbic pathology.
Affective disorders show disrupted rhythmic neuroendocrine control, potentially linked to serotonin receptor function or hypothalamic issues.
Neuroendocrine changes in depression may represent enduring vulnerability traits.

Conclusions:

Neuropeptide and neuroendocrine dysregulation are implicated in the pathophysiology of schizophrenia and affective disorders.
These alterations may serve as vulnerability markers for developing psychotic illnesses.
Future research should focus on the intricate interactions between neuropeptides and neuroendocrine states in psychosis.

Related Experiment Videos